Capital Raising
-
Option Expiry Notice5 May 2023
The directors of Analytica wish to advise that the final date for exercising the Company's listed options ASX Code: ALTOB is 5.00pm (AEDT) on 18TH June 2023
-
Notification of Cessation of Securities9 June 2022
Analytica provides notification regarding the cessation of various options.
-
Federal Government Grant Commitment under the Energy Security and Regional Development Plan16 May 2022
Analytica notes the media release and announcement by Llew O’Brien MP, Federal Member for Wide Bay, and Peter Dutton MP, Federal Member for Dickson offering Analytica $4.8m in government assistance from the Energy Security and Regional Development Plan towards PeriCoach export development and manufacturing facility in Maryborough, Queensland.
-
Notification of Cessation of Securities and Appendix 3Y's22 December 2021
Analytica provides notification regarding the cessation of various options and associated Appendix 3Y announcements for Directors.
-
Change of Substantial and Directors' Holdings22 June 2021
-
Appendix 2A - Options Issued21 June 2021
-
Results of EGM18 June 2021
-
Cleansing Prospectus17 June 2021
-
Notice of Extraordinary General Meeting17 May 2021
Notice is given that an Extraordinary General Meeting will be held at 10am on Friday, 18 June 2021 in the Mayflower Room, 320 Adelaide Street, Brisbane, Australia
-
Form 60430 April 2021
Notice of change of interests of substantial holders Dr Michael Monsour and Dr Peter Corr.
-
Notice under section 708A and Appendix 2A28 April 2021
Analytica has today issued 879,903,083 fully paid ordinary shares in the Company at an issue price of 0.35 cents per share.
-
Placement to Raise up to $3.83m23 Apr 2021
Analytica announce a share placement at an issue price of 0.35 cents per share which will raise up to $3.83 million subject to shareholder approval.
-
Trading Halt21 Apr 2021
ASX advises that Analytica securities have been placed in a trading halt pending an announcement regarding capital raising.
-
Expiry of Unlisted Options9 Dec 2020
The Company advises the expiry of unlisted options at 5pm 9th Dec 2020.
-
Notice of Unlisted Option Expiry28 Feb 2020
Analytica gives notice of unlisted options expiring 28 Feb 2020.
-
Compliance Documents from Entitlement Offer7 June 2019
Analytica presents the following compliance documents from the recent Entitlement Offer.
-
Entitlement offer Raises $913k5 June 2019
Analytica is pleased to announce that it has completed its 1 for 6 pro-rata, non-renounceable entitlement offer announced on 10 May 2019, raising approximately $913,000.
-
Notice of Option Expiry22 May 2019
Analytica gives notice of unlisted options expiring 22 May 2019.
-
Entitlement Offer10 May 2019
A pro-rata, non-renounceable entitlement offer to raise up to ~$2.7m (before offer costs).
-
Expiry of Unlisted Options13 February 2019
The Company advises that 5 million unlisted options at exercise price $0.0439 expired on 5pm 12 February 2019.
-
Notice of Option Expiry30 October 2018
Analytica gives notice of unlisted options expiring 29 October 2018.
-
Appendices 3Y and Forms 604 from May Options and Placements15 June 2018
-
Analytica raises $1,532m from Options and Placements12 June 2018
-
Notice of Option Expiry27 December 2017
Analytica gives notice of unlisted options expiring 31 January 2018.
-
Appendix 3B19 October 2017
Analytica presents an Appendix 3B - New Issue Announcement for securities issued under the recent Entitlement Offer.
-
Completion of Entitlement Offer17 October 2017
Analytica is pleased to announce completion of its 1 for 8 Entitlement Offer.
-
Replacement Prospectus26 September 2017
Analytica presents a replacement prospectus for the entitlement offer announced 18 September.
-
Entitlement Offer18 September 2017
Analytica is pleased to announce that it is proposing to undertake an equity capital raising to raise up to approximately $1.593 million (before offer costs) by way of a renounceable pro-rata entitlement offer to eligible shareholders.
-
Capital Raising Activities31 January 2017
Analytica announces a series of placements.
-
R and D Tax Receipt22 December 2016
Analytica announces the receipt of $1,157k from the Australian Taxation Office under the Research and Development incentive related to the financial year to 30th June 2016.
-
Share placement of $500k to cornerstone investor27 July 2016
Analytica is pleased to announce the further placement of new fully paid ordinary shares to our American Virgin Islands cornerstone investor INOV8 LLC.
-
Share Purchase Plan Results20 April 2016
Analytica is pleased to announce that the Share Purchase Plan was well supported by shareholders with $567,700 being received.
-
Capital Raising18 March 2016
Analytica is pleased to announce the following capital raising initiatives.
-
Rights Issue Update13 August 2015
-
Successful Completion of Rights Issue6 August 2015
Analytica is pleased to announce the successful completion of its partially-underwritten 1 for 2 renounceable pro-rata rights issue.
-
Entitlement Offer – Despatch of Prospectus and Entitlement & Acceptance Form23 July 2015
-
Rights Issue14 July 2015
A partially underwritten, pro-rata, renounceable rights offer to raise up to $3.7m.
-
Rights Issue13 July 2015
Analytica advise the market that the rights offer announced last week aiming to raise up to $3.7m is to be partially underwritten to $2.8m by the Lead Manager Patersons Securities Limited. The company is finalising a prospectus setting out full details of the renounceable pro-rata rights issue. It is anticipated that the prospectus will be lodged and released to the market before commencement of trading on Tuesday 14th July. A revised timetable is at the link.
-
Capital Raising8 July 2015
Analytica is pleased to announce that it is proposing to undertake an equity capital raising to raise up to ~$3.7m (before costs) by a renounceable pro-rata offer to eligible shareholders.
-
Successful Completion of Entitlement Offer31 October 2014
Analytica is pleased to announce that its 1 for 8, $3.17m Entitlement Offer at 3.0 cents per share, has been very well supported by shareholders, with shareholders applying for 85,540,964 shares raising approximately $2.56M. Shares will be allotted on Wednesday 5th November 2014.
-
Entitlement Offer – Despatch of Offer Booklet and Entitlement and Acceptance Form17 October 2014
-
Entitlement Offer8 October 2014
A partially underwritten pro-rata non-renounceable entitlement offer of 1 for 8 at an issue price of $0.03 to raise ~$3.17m.
-
Capital Raising announcement and Investor Presentation3 October 2014
Analytica is pleased to announce that it is undertaking an equity capital raising to raise approximately $4.01 million (before offer costs) in conjunction with Lead Manager, Patersons Securities Limited.
-
Appendix 3B - Entitlement Offer3 October 2014
New issue announcement, application for quotation of additional securities and agreement.
-
Fund Raising Completion20 May 2014
Analytica is pleased to announce that its underwritten 1 for 15 $1.2m Entitlement Offer at 2.4 cents a share, has been very well supported by shareholders, with shareholders applying for $831k of shares.
-
Rights Issue Documentation6 May 2014
Documentation for the Rights Issue: - Chairman's letter, Entitlement Offer Booklet, Acceptance Form and Brochure.
-
Rights Issue23 April 2014
1 for 15 rights issue to eligible shareholders at $0.024 per share.
-
Capital Raising up to $3m in Private Placement and Rights Issue22 April 2014
$1.8m private placement to sophisticated investors at $0.024 per share. 1 for 15 rights issue to existing investors at $0.024 per share. Funding to accelerate marketing of PeriCoach™ which launches this quarter. Included is an investor presentation used during the capital raising.
-
SPP Result8 November 2013
Analytica is pleased to announce it has successfully raised $2.2m in the recent SPP.
-
Share Purchase Plan30 September 2013
Chairman's Letter to shareholders and SPP documentation including application form.
-
Share Purchase Plan27 September 2013
Analytica is pleased to announce a Share Purchase Plan underwritten to $1.8 million, providing shareholders with an opportunity to increase their holding in the company as it continues to advance a number of exciting opportunities.
-
Letter to Option Holders10 May 2013
-
Completion of Rights Issue12 March 2012
Analytica Ltd is pleased to advise the completion of the $2.8 million rights issue. The shortfall of $861,897 has been received by the allotment of shares for underwriting provided by directors.
-
Non-Renounceable Rights Issue Raises $2.8 Million14 December 2011
Analytica advises the Rights Issue closed on 9 December 2011 raised approximately $2.8M. The Rights Issue was fully subscribed when combined with the underwritten amount.
-
Rights Issue - Extension of Offer Period28 November 2011
Analytica Limited advises that the offer period for the current rights issue has been extended to now close on 9 December 2011.
-
Eligible Shareholder Rights Issue Entitlement and Acceptance Form16 November 2011
-
Rights Issue Letters to Shareholders3 November 2011
-
Rights Issue Prospectus2 November 2011
A non-renounceable rights issue of 1 New Share for every 3 Shares held at 2 cents each together with 1 New 4 Cent Option and 1 New 8 Cent Option for every 1 New Share.